pathogenic fungi n.
Skip this Video
Loading SlideShow in 5 Seconds..
PATHOGENIC FUNGI PowerPoint Presentation
Download Presentation

Loading in 2 Seconds...

play fullscreen
1 / 124

PATHOGENIC FUNGI - PowerPoint PPT Presentation

  • Uploaded on

PATHOGENIC FUNGI. Medical mycology. field of medicine concerned with the diagnosis, managements and prevention of mycoses. MYCOSES. diseases caused by fungi Mode of infection: Inhalation Trauma Ingestion Rarely from person to person Most mycoses are not contagious.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
    Presentation Transcript

    2. Medical mycology • field of medicine concerned with the diagnosis, managements and prevention of mycoses

    3. MYCOSES • diseases caused by fungi • Mode of infection: • Inhalation • Trauma • Ingestion • Rarely from person to person • Most mycoses are not contagious

    4. Clinical Manifestations of Mycoses • Fungal infections (most common) • Toxicoses (poisoning) • Allergies (hypersensitivity reactions)

    5. D I A G N O S I S

    6. DIAGNOSIS • Sabourad dextrose agar – the medium where fungi is cultured • Potassium hydroxide (KOH) preparations – dissolve keratin in skin scrapings or biopsy specimens, leaving only fungal cells for examination • Gomori methenamine silver (GMS) stain – used on tissue to stain fungal cells black • Direct immunofluorescence - labeling of antibodies or antigens with fluorescent dyes.

    7. Mycoses are also among the most difficult diseases to heal.

    8. WHY? • Fungi possess the biochemical ability to resist the oxidative damage perpetuated by T cells during cell-mediated immune response • Fungi are eukaryotic and thus biochemically similar to human cells, which means most fungicides are toxic to human tissues

    9. The Gold Standard!!! • Amphotericin B – considered the best drug for treating systemic mycoses and other fungal infections that do not respond to other drugs

    10. The downside….. It is still toxic to humans

    11. The alternative.. • Azole drugs • which only inhibit the fungi (fungistatic) rather than kill it • less toxic to humans • e.g. ketoconazole, itraconazole and fluconazole

    12. Categories of Fungal Agents • True fungal pathogens • Opportunistic fungi

    13. True pathogens • Have the ability to actively attack and invade tissues • Can infect any host, regardless of its immune status

    14. Opportunistic Fungi • Lack genes for proteins that aid in colonizing the body • Do not cause disease in healthy individuals • Can infect only susceptible individuals, those whose body’s defenses are low

    15. The only fungi known to cause disease in humans: • Blastomyces dermatiditis • Coccidiodes immitis • Histoplasma capsulatum • Paracoccidiodes brasiliensis The remaining fungi that cause disease are considered opportunistic fungi.

    16. The following slides may contain scenes not suitable for very young audiences. Those with weak constitutions are asked to continue paying attention no matter how utterly repulsive you may find it to be. VIEWER’S DISCRETION IS ADVISED.


    18. those fungal infections that spread throughout the body result of infections by one of the four pathogenic, dimorphic fungi of the division Ascomycota. SYSTEMIC MYCOSES • Ascomycota:Blastomyces, Coccidioides, Histoplasma, and Paracocidioides

    19. B L A S T O M Y C O S I S

    20. B L A S T O M Y C O S I S • Pathogen:Blastomyces dermatitidis. • B. dermatitidis normally grows in soil rich in organic material, such as decaying vegetation and animal wastes, where cool, damp conditions favor growth and sporulation.

    21. B L A S T O M Y C O S I S • Mode of infection: Inhalation of dust disturbed from the environmental sources carries fungal spores and pieces of hyphae into the lungs.

    22. B L A S T O M Y C O S I S • Pulmonary Blastomycosis – the most common manifestation of Blastomyces infection in humans. • Initial pulmonary lesions are asymptomatic. • If symptoms do develop, they are vague and include cough, fever, malaise, and weight loss.

    23. B L A S T O M Y C O S I S • Cutaneous blastomycosis – consists of generally painless lesions on the face and upper body. • Can be raised and wartlike, craterlike due to the death of tissue.

    24. B L A S T O M Y C O S I S • Osteoarticular blastomycosis – a condition where fungus spreads to the spine, pelvis, cranium, ribs, long bones, or subcutaneous tissues surrounding joints.

    25. Patients with Cutaneous blastomycosis - • painless lesions on the face and upper body.

    26. B L A S T O M Y C O S I S • Diagnosis – relies on identification of B. dermatitis following culture, or direct examination of various samples such as sputum, bronchial washings, biopsies, cerebrospinal fluid, or skin scrapings. • Treatment – amphotericin for 10 weeks.


    28. COCCIDIOIDOMYCOSIS Pathogen: Coccidioides immitis • Can be recovered from desert soil, rodent burrows, archaeological remains, and mines. • Once inhaled in dust, anthrospores become trapped in the alveolar spaces of the lungs.

    29. COCCIDIOIDOMYCOSIS • Major manifestation - pulmonary • Invasion of the CNS may result in meningitis, headache, nausea, and emotional disturbance

    30. COCCIDIOIDOMYCOSIS • Diagnosis – based on the identification of spherules in KOH- or GMS- treated samples collected from patients • Amphotericin B – the drug of choice

    31. H I S T O P L A S M O S I S

    32. H I S T O P L A S M O S I S • Pathogen: Histoplasma capsulatum • most common fungal pathogen affecting humans. • Two strains recognized: • a. strain capsulatum - intracellular parasite, first attacks alveolar macrophages in lungs • b. strain duboisii - limited to Africa.

    33. H I S T O P L A S M O S I S • Diagnosis – based on the identification of the distinctive budding yeast in KOH- or GMS- prepared samples of skin scrapings, sputum, cerebrospinal fluid, or various tissues.

    34. Lungs of normal person and a patient with histoplasmosis

    35. H I S T O P L A S M O S I S TREATMENT: • Amphotericin B - prescribed when symptoms do not resolve. • Ketoconazole – used to treat mild infections.


    37. PARACOCCIDIOIDOMYCOSIS • Pathogen: Paracoccidioides brasiliensis • chronic granulomatous disease that characteristically produces a primary pulmonary infection, and then disseminates to form ulcerative granulomata of the buccal, nasal and occasionally the gastrointestinal mucosa.

    38. Paracoccidiomycosis patients – ulcerative granulomata of the buccal, nasal mucosa…

    39. PARACOCCIDIOIDOMYCOSIS • Diagnosis - KOH or GMS preparations of tissue samples revealing yeast cells with multiple buds in a “steering wheel” formation. Steering wheel apperance

    40. PARACOCCIDIOIDOMYCOSIS • Treatment - Amphotericin B or Ketoconazole

    41. End of slideshow, click to exit. Aww… sorry, wrong number..